STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Aspen Aerogels, Inc. Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Aspen Aerogels (NYSE: ASPN) reported Q3 2025 revenue of $73.0M and a net loss of $6.3M on Nov 6, 2025. Revenue fell from $117.3M in Q3 2024; adjusted EBITDA was $6.3M. The company updated full‑year 2025 guidance to $270–280M revenue and adjusted EBITDA of $7–15M, citing lower near‑term U.S. EV production.

Key items: PyroThin award from a major European OEM with production start targeted in 2027, $152.4M cash, $15M operating cash flow, and a $287.6M impairment charge reflected in outlook.

Aspen Aerogels (NYSE: ASPN) ha riportato i ricavi del Q3 2025 di 73,0 milioni di dollari e una perdita netta di 6,3 milioni di dollari il 6 novembre 2025. I ricavi sono diminuiti rispetto ai 117,3 milioni di dollari nel Q3 2024; l'EBITDA rettificato è stato di 6,3 milioni di dollari. L'azienda ha aggiornato la guidance per l'intero 2025 a ricavi di 270–280 milioni di dollari e EBITDA rettificato di 7–15 milioni di dollari, citando una minore produzione di veicoli elettrici statunitense a breve termine.

Elementi chiave: Premio PyroThin da un importante OEM europeo con avvio della produzione previsto per il 2027, 152,4 milioni di dollari di cassa, flusso di cassa operativo di 15 milioni di dollari, e un onere di impairment di 287,6 milioni di dollari riflesso nelle prospettive.

Aspen Aerogels (NYSE: ASPN) informó ingresos del tercer trimestre de 2025 de 73,0 millones de dólares y una pérdida neta de 6,3 millones de dólares el 6 de noviembre de 2025. Los ingresos cayeron desde 117,3 millones en el Q3 2024; el EBITDA ajustado fue de 6,3 millones. La compañía actualizó la guía para todo 2025 a 270–280 millones de ingresos y EBITDA ajustado de 7–15 millones, citando una menor producción de vehículos eléctricos en EE. UU. a corto plazo.

Elementos clave: premio PyroThin de un OEM europeo importante con inicio de producción previsto para 2027, 152,4 millones de dólares en caja, flujo de caja operativo de 15 millones, y un cargo por deterioro de 287,6 millones de dólares reflejado en las perspectivas.

Aspen Aerogels (NYSE: ASPN)은 2025년 3분기 매출 7300만 달러와 2025년 11월 6일 기준 순손실 630만 달러를 보고했습니다. 매출은 2024년 3분기 1억1730만 달러에서 감소했습니다; 조정된 EBITDA는 630만 달러였습니다. 회사는 연간 2025년 가이던스를 2.70–2.80억 달러의 매출과 700만–1500만 달러의 조정 EBITDA로 상향 조정했으며, 단기 미국 전기차 생산이 둔화될 것이라고 밝혔습니다.

핵심 항목: PyroThin 상을 얻은 유럽의 주요 OEM으로부터의 수상으로 생산 시작은 2027년으로 예상되고, 이 cash 15.24억 달러, 영업 현금흐름 1500만 달러, 전망에 반영된 2억 8760만 달러의 impairment 비용이 포함되어 있습니다.

Aspen Aerogels (NYSE: ASPN) a annoncé le chiffre d'affaires du T3 2025 de 73,0 M$ et une perte nette de 6,3 M$ le 6 novembre 2025. Le chiffre d'affaires a diminué par rapport à 117,3 M$ au T3 2024; l'EBITDA ajusté était de 6,3 M$. L'entreprise a relevé ses prévisions pour l'ensemble de 2025 à 270–280 M$ de chiffre d'affaires et EBITDA ajusté de 7–15 M$, citant une production de véhicules électriques américains à court terme plus faible.

Points clés: récompense PyroThin d'un OEM européen majeur avec un démarrage de production prévu en 2027, 152,4 M$ de trésorerie, flux de trésorerie opérationnel de 15 M$, et une charge d'impairement de 287,6 M$ reflétée dans les perspectives.

Aspen Aerogels (NYSE: ASPN) meldete am 6. November 2025 für das Q3 2025 einen Umsatz von 73,0 Mio. USD und einen Nettverlust von 6,3 Mio. USD. Der Umsatz fiel von 117,3 Mio. USD im Q3 2024; das adjustierte EBITDA betrug 6,3 Mio. USD. Das Unternehmen hob die Guidance für das Gesamtjahr 2025 auf einen Umsatz von 270–280 Mio. USD und ein adjustiertes EBITDA von 7–15 Mio. USD an und verwies auf eine geringere Near-Term-US-EV-Produktion.

Wichtige Punkte: PyroThin-Auszeichnung von einem großen europäischen OEM mit geplantem Produktionsbeginn im Jahr 2027, 152,4 Mio. USD in bar, operativer Cashflow von 15 Mio. USD, und eine Impairment-Aufwendung von 287,6 Mio. USD, die in der Perspektive berücksichtigt wird.

Aspen Aerogels (NYSE: ASPN) أعلنت عن إيرادات الربع الثالث 2025 بمقدار 73.0 مليون دولار وخسارة صافية قدرها 6.3 مليون دولار في 6 نوفمبر 2025. انخفضت الإيرادات من 117.3 مليون دولار في الربع الثالث 2024؛ EBITDA المعدلة كانت 6.3 مليون دولار. قامت الشركة بتحديث التوجيه للسنة الكاملة 2025 إلى إيرادات قدرها 270–280 مليون دولار و EBITDA المعدلة من 7–15 مليون دولار، مشيرة إلى انخفاض إنتاج المركبات الكهربائية الأمريكية في المدى القريب.

النقاط الأساسية: جائزة PyroThin من جهة تصنيع أصلية أوروبية كبرى مع بدء الإنتاج المتوقع في 2027، 152.4 مليون دولار نقداً، التدفق النقدي التشغيلي 15 مليون دولار، ومصاريف انخفاض قيمة بقيمة 287.6 مليون دولار مذكورة في التوقعات.

Positive
  • Awarded PyroThin contract from a major EU OEM; SOP expected in 2027
  • Energy Industrial revenue +7% quarter‑over‑quarter
  • Ended quarter with $152.4M cash and equivalents
  • Generated $15M operating cash flow in Q3 2025
Negative
  • Total revenue down to $73.0M in Q3 2025 from $117.3M in Q3 2024
  • Adjusted EBITDA guidance cut to $7–15M from prior $35–45M
  • Updated FY 2025 net loss widened to $(342)–(334)M
  • Impairment of property, plant, and equipment of $287.6M included in outlook
  • Gross margin declined to 28.5%, a 4‑percentage‑point QoQ decrease

Insights

Revenue fell sharply and management cut full-year guidance; large impairment drives substantially worse earnings outlook.

Third-quarter revenue declined to $73.0 million from $117.3 million year-over-year and the company recorded an impairment of property, plant, and equipment of $287.6 million. Adjusted EBITDA for the quarter fell to $6.3 million and the updated FY 2025 Adjusted EBITDA outlook tightened to a range of $7$15 from a prior $35$45 range, while full-year revenue guidance was lowered to $270$280.

Key risks are clear and disclosed: sizable impairment charges and lowered profitability metrics materially change reported and adjusted results through 2025. Monitor the company's ability to convert working capital improvements (cash and equivalents were $152.4 million; operating cash flow generated $15 million) into sustainable margin recovery over the next 12 months, and watch production start dates such as the PyroThin® program which expects start of production in 2027.

Thermal Barrier demand softened in North America; Energy Industrial shows near-term resilience with projects expected to lift 2026.

Quarterly segmentation shows Thermal Barrier revenue of $48.7 million down sequentially while Energy Industrial rose to $24.3 million, and management cites lower near-term U.S. EV production as the driver of the Thermal Barrier reset. The company highlighted an EU OEM PyroThin® award and expects LNG and Subsea opportunities to support Energy Industrial growth in 2026.

Dependencies are explicit: recovery in Thermal Barrier relies on EV production dynamics and the European program ramp; Energy Industrial improvement depends on project awards and execution. Track the advertised program timelines, quarterly gross margin trends (gross margin was 28.5%, down four percentage points QoQ) and any additional restructuring or impairment items disclosed for the remainder of 2025.

Full-year 2025 outlook updated to reflect lower near-term EV production in North America
PyroThin® award from a major EU OEM demonstrates technology leadership & supports growth opportunities
LNG and Subsea project opportunities expected to drive Energy Industrial growth in 2026

NORTHBOROUGH, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in sustainability and electrification solutions, today announced financial results for the third quarter of 2025, and discussed recent business developments.

Total revenue for the third quarter of 2025 was $73.0 million, compared to $117.3 million in the third quarter of 2024.

Net loss was $6.3 million, which included $1.6 million of restructuring and impairment charges, compared to net loss of $13.0 million in the third quarter of 2024. Adjusting net loss for the restructuring and impairment charges would result in a net loss of $4.8 million. Net loss per share was $0.08, compared to net loss per share of $0.17 in the third quarter of 2024. Adjusting net loss per share for the restructuring and impairment costs would result in a net loss per share of $0.06.

Adjusted EBITDA for the third quarter of 2025 was $6.3 million, compared to $25.4 million in the third quarter of 2024.

A reconciliation of GAAP financial results to non-GAAP financial results are provided in the financial schedules that are part of this press release. An explanation of these non-GAAP financial measures are also included below under the heading "Non-GAAP Financial Measures."

Recent Business Highlights & Quarterly Performance

  • Company revenues of $73.0 million, a 6% decrease quarter-over-quarter (QoQ)
    • Thermal Barrier: $48.7 million of revenue, a 12% decrease QoQ
    • Energy Industrial: $24.3 million of revenue, a 7% increase QoQ
  • Delivered gross margins of 28.5%, a four-percentage point decrease QoQ
  • Net loss of $6.3 million, a $2.7 million improvement QoQ
  • Adjusted EBITDA of $6.3 million, a $3.5 million decrease QoQ
  • Ended the quarter with cash and equivalents of $152.4 million
  • Generated $15 million of operating cash flow, reflecting ongoing working capital optimization initiatives
  • Awarded PyroThin® Thermal Barrier contract from a major European OEM with expected start of production in 2027

“The U.S. EV environment has created a challenging backdrop after a period of significant development. We expect to rebuild growth in our Thermal Barrier business after the market stabilizes, supported by the ramp-up of our European programs, including our newest award,” commented Don Young, Aspen's President and CEO.

“We anticipate a strong 2026 for our Energy Industrial business as project activity normalizes. We also see near-term revenue opportunities from our diversification into adjacent markets. Our focus remains on driving growth through innovation and building a profitable, capital-efficient business,” added Young.

2025 Financial Outlook
Aspen’s updated full-year 2025 outlook is as follows:

($ in millions, except per share amounts – figures may not total due to rounding)  
MetricYTD ActualsPrior
FY 2025 Outlook
Updated
FY 2025 Outlook
Revenue230297 - 317270 – 280
Net Income (Loss)(317)(317) – (307)(342) – (334)
Earnings Per Share (Basic)(3.85)(3.86) – (3.73)(4.15) – (4.05)
Adjusted EBITDA2135 – 457 – 15
CAPEX*202525
    

*Capital Expenditures excluding costs related to the Statesboro plant project, which totaled $15.4 million year-to-date as of 9/30/2025

“As we reset our outlook to reflect lower near-term demand in the U.S. EV market, we remain focused on the elements within our control,” said Grant Thoele, Chief Financial Officer and Treasurer. “Throughout 2025, we’ve taken decisive actions to reduce fixed costs and improve operating efficiency, fortifying the foundation of the business. In addition to strengthening our core markets, we are focused on driving growth through disciplined execution, thoughtful diversification, and developing strategic partnerships.”

The Company's 2025 outlook assumes depreciation and amortization of $22.5 million, stock-based compensation expense of $10.5 million, other expense (net) of $11.5 million, restructuring and demobilization costs of $16.5 million, impairment of property, plant, and equipment of $287.6 million, and weighted average shares outstanding of 82.3 million for the full year.

A reconciliation of net loss to non-GAAP Adjusted EBITDA for the 2025 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading “Non-GAAP Financial Measures.”

Aspen may incur, among other items, additional charges, realize gains or losses, incur financing costs or interest expense, or experience other events in 2025, including those related to supply chain disruptions, or further cost inflation, that could cause actual results to vary materially from this outlook. See Special Note Regarding Forward-Looking and Cautionary Statements below.

Conference Call and Webcast Notification
A conference call with Aspen management to discuss third quarter 2025 results and recent business developments will be held Thursday, November 6, 2025 at 8:30 a.m. EST. During the call, management will respond to questions concerning, but not limited to, Aspen's financial performance, business conditions, and financial outlook. Management's discussion and responses could contain information that has not been previously disclosed.

Shareholders and other interested parties may call +1 (404) 975-4839 (domestic) or +1 (929) 526-1599 (international) and reference conference ID "877424" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted at the Investors section of Aspen's website, www.aerogel.com.

Following the live event, an archived version of the webcast will be available on Aspen's website for convenient on-demand replay for at least a year. A copy of this press release is posted in the Investors section on Aspen's website.

Non-GAAP Financial Measures
In addition to providing financial measurements based on generally accepted accounting principles in the United States of America ("GAAP"), Aspen provides additional financial metrics that are not prepared in accordance with GAAP ("non-GAAP"). The non-GAAP financial measures included in this press release are Adjusted EBITDA, adjusted net loss and adjusted net loss per share. Management uses these non-GAAP financial measures, in addition to GAAP financial measures, as a measure of operating performance because the non-GAAP financial measures do not include the impact of items that management does not consider indicative of Aspen's core operating performance. In addition, management uses Adjusted EBITDA (i) for planning purposes, including the preparation of Aspen's annual operating budget, (ii) to allocate resources to enhance the financial performance of its business, and (iii) as a performance measure under its bonus plan.

Management believes that these non-GAAP financial measures reflect Aspen's ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as it excludes expenses and gains not reflective of Aspen's ongoing operating results or that may be infrequent and/or unusual in nature. Management also believes that these non-GAAP financial measures provides useful information to investors in understanding and evaluating Aspen's operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. These non-GAAP measures may not be comparable to similarly titled measures presented by other companies.

The non-GAAP financial measures do not replace the presentation of Aspen's GAAP financial results and should only be used as a supplement to, not as a substitute for, Aspen's financial results presented in accordance with GAAP. In this press release, Aspen has provided a reconciliation of Adjusted EBITDA to net income (loss), adjusted net loss to net loss and adjusted net loss per share to net loss per share, in each case the most directly comparable GAAP financial measure. Management strongly encourages investors to review Aspen's financial statements and publicly filed reports in their entirety and not rely on any single financial measure.

About Aspen Aerogels, Inc.
Aspen is a technology leader in sustainability and electrification solutions. The Company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility and clean energy. Aspen's PyroThin® products enable solutions to thermal runaway challenges within the electric vehicle ("EV") market. The Company's Cryogel® and Pyrogel® products are valued by the world's largest energy infrastructure companies. Aspen's strategy is to partner with world-class industry leaders to leverage its Aerogel Technology Platform® into additional high-value markets. Aspen is headquartered in Northborough, Mass. For more information, please visit www.aerogel.com.

Special Note Regarding Forward-Looking and Cautionary Statements
This press release and any related discussion contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen’s financial outlook for the full year 2025. These statements are not historical facts but rather are based on Aspen’s current expectations, estimates and projections regarding Aspen's business, operations and other factors relating thereto, including with respect to Aspen’s financial outlook for the full year 2025. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” “outlook,” “assumes,” “targets,” “opportunity,” and similar expressions are used to identify these forward-looking statements. Such forward-looking statements include statements regarding, among other things, Aspen’s beliefs and expectations about revenue, cash flow, gross profit, gross margin, operating margin, net income (loss), Adjusted EBITDA, profitability, capacity, revenue capacity, backlog, costs, expenses, and related increases, decreases, trends or timing, including with respect to Aspen’s beliefs and expectations about the EV and energy industrial market; Aspen’s potential revenue capacity and gross margins; Aspen’s efforts to demobilize its previously planned second manufacturing plant in Statesboro, Georgia; Aspen’s efforts to manage the capacity of its manufacturing plant in East Providence, Rhode Island and its external manufacturing facility to meet expected customer demand; current or future trends in the EV and energy infrastructure markets, as well as in adjacent market opportunities such as energy storage applications, electrification applications and other potential adjacent applications; the impact of market trends on Aspen’s business; the strength, effectiveness, productivity, costs, potential profitability or other fundamentals of Aspen’s business; beliefs about the role of Aspen’s technology and opportunities in the EV and energy infrastructure markets, including LNG and Subsea; beliefs about Aspen’s ability to provide and deliver products and services to EV and energy infrastructure customers; beliefs about content per vehicle, revenue, costs, expenses, profitability, investments or cash flow associated with Aspen’s EV opportunities, including the EV thermal barrier business; and the performance and market acceptance of Aspen’s products. All such forward-looking statements are based on management’s present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following: ongoing uncertainty in the EV and energy infrastructure markets and potential demand for Aspen’s products; inability to execute Aspen’s long-term growth plan; the right of EV thermal barrier customers to cancel contracts with Aspen at any time and without penalty; any costs, expenses, or investments incurred by Aspen in excess of projections used to develop pricing for Aspen’s products; Aspen’s inability to create customer or market opportunities for its products; any failure to enforce any of Aspen’s patents; the general economic conditions and cyclical demands in the markets that Aspen serves; the impact of changes in government and economic policies, incentives, and tariffs on Aspen's customers, production, sales, cost structure, competitive landscape and results of operations; and the other risk factors discussed under the heading “Risk Factors” in Aspen’s Annual Report on Form 10-K for the year ended December 31, 2024 and filed with the Securities and Exchange Commission (“SEC”) on February 27, 2025, as well as any updates to those risk factors filed from time to time in Aspen’s subsequent periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release. Aspen does not intend to update this information unless required by law.

Investor Relations Contacts:
Neal Baranosky
nbaranosky@aerogel.com
Phone: (508) 691-1111 x 8

Georg Venturatos / Patrick Hall
Gateway Group
ASPN@gateway-grp.com
Phone: (949) 574-3860


ASPEN AEROGELS, INC.
Condensed Consolidated Balance Sheets
(Unaudited and in thousands)
 
       
  September 30,  December 31, 
  2025  2024 
  (In thousands) 
Assets      
Current assets:      
Cash and cash equivalents $150,722  $220,882 
Restricted cash  1,710   394 
Accounts receivable, net  69,149   109,104 
Inventories  43,037   47,551 
Prepaid expenses and other current assets  14,299   31,517 
Total current assets  278,917   409,448 
Property, plant and equipment, net  154,370   459,276 
Assets held for sale  25,504    
Operating lease right-of-use assets  17,557   20,854 
Finance lease right-of-use assets  6,423    
Other long-term assets  8,624   5,566 
Total assets $491,395  $895,144 
Liabilities and Stockholders’ Equity      
Current liabilities:      
Accounts payable $19,098  $44,361 
Accrued expenses  15,585   36,495 
Deferred revenue  824   2,199 
Finance obligation for sale and leaseback transactions  4,265   4,028 
Operating lease liabilities  3,243   3,279 
Finance lease liabilities  1,724    
Long term debt - current portion  26,000   19,750 
Total current liabilities  70,739   110,112 
Revolving line of credit  14,252   42,131 
Long term debt  70,090   94,961 
Finance obligation for sale and leaseback transactions long-term  6,133   10,087 
Operating lease liabilities long-term  20,745   23,148 
Finance lease liabilities long-term  3,703    
Total liabilities  185,662   280,439 
Stockholders’ equity:      
Total stockholders’ equity  305,733   614,705 
Total liabilities and stockholders’ equity $491,395  $895,144 



ASPEN AEROGELS, INC.
Consolidated Statements of Operations
(Unaudited and in thousands, except share and per share data)
 
  Three Months Ended  Nine Months Ended 
  September 30,  September 30, 
  2025  2024  2025  2024 
  (In thousands, except
share and per share data)
 
Revenue $73,017  $117,340  $229,764  $329,611 
Cost of revenue  52,218   68,297   160,837   193,847 
Gross profit  20,799   49,043   68,927   135,764 
Operating expenses:            
Research and development  2,494   4,591   10,621   13,645 
Sales and marketing  6,553   9,306   21,885   27,130 
General and administrative  13,532   17,746   40,402   52,465 
Restructuring and demobilization costs  1,568      16,296    
Impairment of property, plant and equipment        287,567   2,702 
Total operating expenses  24,147   31,643   376,771   95,942 
Income (loss) from operations  (3,348)  17,400   (307,844)  39,822 
Other income (expense)            
Interest expense, convertible note - related party     (1,469)     (7,550)
Interest expense  (2,973)  (1,147)  (8,015)  (883)
Loss on extinguishment of debt     (27,487)     (27,487)
Other income  581      1,711    
Total other expense  (2,392)  (30,103)  (6,304)  (35,920)
Income (loss) before income tax expense  (5,740)  (12,703)  (314,148)  3,902 
Income tax expense  (594)  (267)  (2,491)  (1,889)
Net income (loss) $(6,334) $(12,970) $(316,639) $2,013 
Net income (loss) per share:            
Basic $(0.08) $(0.17) $(3.85) $0.03 
Diluted $(0.08) $(0.17) $(3.85) $0.03 
Weighted-average common shares outstanding:            
Basic  82,399,599   76,261,294   82,216,027   76,402,123 
Diluted  82,399,599   76,261,294   82,216,027   79,149,193 


Analysis of Cash Flow

The following table summarizes our cash flows for the periods indicated.

  Nine Months Ended 
  September 30, 
  2025  2024 
  (In thousands) 
Net cash provided by (used in):      
Operating activities $16,737  $9,865 
Investing activities  (34,985)  (71,511)
Financing activities  (50,596)  35,558 
Net decrease in cash  (68,844)  (26,088)
Cash, cash equivalents and restricted cash at beginning of period  221,276   139,971 
Cash, cash equivalents and restricted cash at end of period $152,432  $113,883 


  Three Months Ended 
  March 31, 2025  June 30, 2025  September 30, 2025 
  (In thousands) 
Net cash provided by (used in):         
Operating activities $5,632  $(3,930) $15,035 
Investing activities  (12,998)  (12,885)  (9,102)
Financing activities  (21,477)  (7,586)  (21,533)
Net (decrease) increase in cash  (28,843)  (24,401)  (15,600)
Cash, cash equivalents and restricted cash at beginning of period  221,276   192,433   168,032 
Cash, cash equivalents and restricted cash at end of period $192,433  $168,032  $152,432 


Reconciliation of Non-GAAP Financial Measures

The following tables present a reconciliation of the non-GAAP financial measure included in this press release to the most directly comparable GAAP measure:

Reconciliation of Adjusted EBITDA to Net income (loss)

We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance.

For the three and nine months ended September 30, 2025 and 2024:

  Three Months Ended  Nine Months Ended 
  September 30,  September 30, 
  2025  2024  2025  2024 
  (In thousands) 
Net income (loss) $(6,334) $(12,970) $(316,639) $2,013 
Depreciation and amortization  5,393   5,321   16,981   17,093 
Stock-based compensation  2,642   2,630   7,927   10,307 
Other expense  2,392   2,616   6,304   8,433 
Income tax expense  594   267   2,491   1,889 
Loss on extinguishment of debt  -   27,487   -   27,487 
Restructuring and demobilization costs  1,568   -   16,296   - 
Impairment of property, plant and equipment  -   -   287,567   - 
Adjusted EBITDA $6,255  $25,351  $20,927  $67,222 


Other Information

The following tables reconcile net income (loss) and net income (loss) per share to adjusted net income (loss) and adjusted net income (loss) per share for the three and nine months ended September 30, 2025 and 2024:

  Three Months Ended 
  September 30, 2025  September 30, 2024 
  Amount  Per Share  Amount  Per Share 
  (In thousands)     (In thousands)    
Net loss $(6,334) $(0.08) $(12,970) $(0.17)
Restructuring and demobilization costs  1,568   0.02      - 
Impairment of property, plant and equipment     -      - 
Adjusted Net Loss $(4,766) $(0.06) $(12,970) $(0.17)


  Nine Months Ended 
  September 30, 2025  September 30, 2024 
  Amount  Per Share  Amount  Per Share 
  (In thousands)     (In thousands)    
Net income (loss) $(316,639) $(3.85) $2,013  $0.03 
Restructuring and demobilization costs  16,296   0.20      - 
Impairment of property, plant and equipment  287,567   3.50      - 
Adjusted Net Income (Loss) $(12,776) $(0.16) $2,013  $0.03 


For the 2025 full year financial outlook:

  Current Outlook 
  Year Ending 
  December 31, 2025 
  Low  High 
  (In thousands) 
Net loss $(341,600) $(333,600)
Depreciation and amortization  22,500   22,500 
Stock-based compensation  10,500   10,500 
Other expense, net  11,500   11,500 
Restructuring and demobilization costs  16,500   16,500 
Impairment of property, plant and equipment  287,600   287,600 
Adjusted EBITDA $7,000  $15,000 


  Prior Outlook 
  Year Ending 
  December 31, 2025 
  Low  High 
  (In thousands) 
Net loss $(316,805) $(306,805)
Depreciation and amortization  24,789   24,789 
Stock-based compensation  10,284   10,284 
Other expense, net  11,109   11,109 
Restructuring and demobilization costs  17,728   17,728 
Impairment of property, plant and equipment  287,567   287,567 
Adjusted EBITDA $34,672  $44,672 



FAQ

What revenue did Aspen Aerogels (ASPN) report for Q3 2025?

Aspen reported $73.0 million in total revenue for Q3 2025.

How did Aspen update its full‑year 2025 guidance on Nov 6, 2025?

The company updated 2025 revenue to $270–280M and adjusted EBITDA to $7–15M.

What caused Aspen's 2025 outlook change and how does it affect ASPN shareholders?

Management cited lower near‑term U.S. EV production; outlook shows wider FY net loss and reduced adjusted EBITDA, which may pressure near‑term earnings expectations.

When will Aspen start production for the awarded PyroThin program and which market is it tied to?

The PyroThin Thermal Barrier award is from a major European OEM with expected start of production in 2027.

What material non‑cash charge did Aspen include in its 2025 outlook?

The outlook includes an $287.6 million impairment of property, plant, and equipment.

How much cash did Aspen Aerogels report at the end of Q3 2025 and was cash flow positive?

Aspen ended the quarter with $152.4 million in cash and reported $15 million of operating cash flow.
Aspen Aerogels Inc

NYSE:ASPN

ASPN Rankings

ASPN Latest News

ASPN Latest SEC Filings

ASPN Stock Data

592.17M
68.87M
16.32%
73.27%
11.29%
Building Products & Equipment
Wholesale-lumber & Other Construction Materials
Link
United States
NORTHBOROUGH